Literature DB >> 32284705

Autosomal Dominantly Inherited Alzheimer Disease: Analysis of genetic subgroups by Machine Learning.

Diego Castillo-Barnes1, Li Su2, Javier Ramírez1, Diego Salas-Gonzalez1, Francisco J Martinez-Murcia3, Ignacio A Illan1, Fermin Segovia1, Andres Ortiz3, Carlos Cruchaga4, Martin R Farlow5, Chengjie Xiong6, Neil R Graff-Radford7, Peter R Schofield8, Colin L Masters9, Stephen Salloway10, Mathias Jucker11, Hiroshi Mori12, Johannes Levin13, Juan M Gorriz1,2.   

Abstract

Despite subjects with Dominantly-Inherited Alzheimer's Disease (DIAD) represent less than 1% of all Alzheimer's Disease (AD) cases, the Dominantly Inherited Alzheimer Network (DIAN) initiative constitutes a strong impact in the understanding of AD disease course with special emphasis on the presyptomatic disease phase. Until now, the 3 genes involved in DIAD pathogenesis (PSEN1, PSEN2 and APP) have been commonly merged into one group (Mutation Carriers, MC) and studied using conventional statistical analysis. Comparisons between groups using null-hypothesis testing or longitudinal regression procedures, such as the linear-mixed-effects models, have been assessed in the extant literature. Within this context, the work presented here performs a comparison between different groups of subjects by considering the 3 genes, either jointly or separately, and using tools based on Machine Learning (ML). This involves a feature selection step which makes use of ANOVA followed by Principal Component Analysis (PCA) to determine which features would be realiable for further comparison purposes. Then, the selected predictors are classified using a Support-Vector-Machine (SVM) in a nested k-Fold cross-validation resulting in maximum classification rates of 72-74% using PiB PET features, specially when comparing asymptomatic Non-Carriers (NC) subjects with asymptomatic PSEN1 Mutation-Carriers (PSEN1-MC). Results obtained from these experiments led to the idea that PSEN1-MC might be considered as a mixture of two different subgroups including: a first group whose patterns were very close to NC subjects, and a second group much more different in terms of imaging patterns. Thus, using a k-Means clustering algorithm it was determined both subgroups and a new classification scenario was conducted to validate this process. The comparison between each subgroup vs. NC subjects resulted in classification rates around 80% underscoring the importance of considering DIAN as an heterogeneous entity.

Entities:  

Keywords:  Alzheimer’s Disease (AD); DIAN; Dominantly-Inherited Alzheimer’s Disease (DIAD); Machine Learning; Neuroimaging

Year:  2020        PMID: 32284705      PMCID: PMC7153760          DOI: 10.1016/j.inffus.2020.01.001

Source DB:  PubMed          Journal:  Inf Fusion        ISSN: 1566-2535            Impact factor:   12.975


  76 in total

1.  High-resolution intersubject averaging and a coordinate system for the cortical surface.

Authors:  B Fischl; M I Sereno; R B Tootell; A M Dale
Journal:  Hum Brain Mapp       Date:  1999       Impact factor: 5.038

2.  A hybrid approach to the skull stripping problem in MRI.

Authors:  F Ségonne; A M Dale; E Busa; M Glessner; D Salat; H K Hahn; B Fischl
Journal:  Neuroimage       Date:  2004-07       Impact factor: 6.556

3.  Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.

Authors:  Yakeel T Quiroz; Aaron P Schultz; Kewei Chen; Hillary D Protas; Michael Brickhouse; Adam S Fleisher; Jessica B Langbaum; Pradeep Thiyyagura; Anne M Fagan; Aarti R Shah; Martha Muniz; Joseph F Arboleda-Velasquez; Claudia Munoz; Gloria Garcia; Natalia Acosta-Baena; Margarita Giraldo; Victoria Tirado; Dora L Ramírez; Pierre N Tariot; Bradford C Dickerson; Reisa A Sperling; Francisco Lopera; Eric M Reiman
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

Review 4.  Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Authors:  Bruno Dubois; Harald Hampel; Howard H Feldman; Philip Scheltens; Paul Aisen; Sandrine Andrieu; Hovagim Bakardjian; Habib Benali; Lars Bertram; Kaj Blennow; Karl Broich; Enrica Cavedo; Sebastian Crutch; Jean-François Dartigues; Charles Duyckaerts; Stéphane Epelbaum; Giovanni B Frisoni; Serge Gauthier; Remy Genthon; Alida A Gouw; Marie-Odile Habert; David M Holtzman; Miia Kivipelto; Simone Lista; José-Luis Molinuevo; Sid E O'Bryant; Gil D Rabinovici; Christopher Rowe; Stephen Salloway; Lon S Schneider; Reisa Sperling; Marc Teichmann; Maria C Carrillo; Jeffrey Cummings; Cliff R Jack
Journal:  Alzheimers Dement       Date:  2016-03       Impact factor: 21.566

5.  Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

Authors:  J C Morris
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

6.  Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.

Authors:  John M Ringman; Sarah Monsell; Denise W Ng; Yan Zhou; Andy Nguyen; Giovanni Coppola; Victoria Van Berlo; Mario F Mendez; Spencer Tung; Sandra Weintraub; Marek-Marsel Mesulam; Eileen H Bigio; Darren R Gitelman; Amanda O Fisher-Hubbard; Roger L Albin; Harry V Vinters
Journal:  J Neuropathol Exp Neurol       Date:  2016-02-17       Impact factor: 3.685

7.  Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.

Authors:  Eric M Reiman; Yakeel T Quiroz; Adam S Fleisher; Kewei Chen; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio; Anne M Fagan; Aarti R Shah; Sergio Alvarez; Andrés Arbelaez; Margarita Giraldo; Natalia Acosta-Baena; Reisa A Sperling; Brad Dickerson; Chantal E Stern; Victoria Tirado; Claudia Munoz; Rebecca A Reiman; Matthew J Huentelman; Gene E Alexander; Jessica B S Langbaum; Kenneth S Kosik; Pierre N Tariot; Francisco Lopera
Journal:  Lancet Neurol       Date:  2012-11-06       Impact factor: 44.182

Review 8.  Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).

Authors:  Mengxuan Tang; Davis C Ryman; Eric McDade; Mateusz S Jasielec; Virginia D Buckles; Nigel J Cairns; Anne M Fagan; Alison Goate; Daniel S Marcus; Chengjie Xiong; Ricardo F Allegri; Jasmeer P Chhatwal; Adrian Danek; Martin R Farlow; Nick C Fox; Bernardino Ghetti; Neill R Graff-Radford; Christopher Laske; Ralph N Martins; Colin L Masters; Richard P Mayeux; John M Ringman; Martin N Rossor; Stephen P Salloway; Peter R Schofield; John C Morris; Randall J Bateman
Journal:  Lancet Neurol       Date:  2016-10-21       Impact factor: 44.182

Review 9.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

10.  Combining PET images and neuropsychological test data for automatic diagnosis of Alzheimer's disease.

Authors:  Fermín Segovia; Christine Bastin; Eric Salmon; Juan Manuel Górriz; Javier Ramírez; Christophe Phillips
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

View more
  2 in total

1.  Radiomics Features Predict Telomerase Reverse Transcriptase Promoter Mutations in World Health Organization Grade II Gliomas via a Machine-Learning Approach.

Authors:  Shengyu Fang; Ziwen Fan; Zhiyan Sun; Yiming Li; Xing Liu; Yuchao Liang; Yukun Liu; Chunyao Zhou; Qiang Zhu; Hong Zhang; Tianshi Li; Shaowu Li; Tao Jiang; Yinyan Wang; Lei Wang
Journal:  Front Oncol       Date:  2021-02-11       Impact factor: 6.244

2.  APP, PSEN1, and PSEN2 Variants in Alzheimer's Disease: Systematic Re-evaluation According to ACMG Guidelines.

Authors:  Xuewen Xiao; Hui Liu; Xixi Liu; Weiwei Zhang; Sizhe Zhang; Bin Jiao
Journal:  Front Aging Neurosci       Date:  2021-06-18       Impact factor: 5.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.